Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Respirology ; 28(7): 636-648, 2023 Jul.
Article in English | MEDLINE | ID: covidwho-2270450

ABSTRACT

BACKGROUND AND OBJECTIVE: People living with asthma, their carers, clinicians and policymakers are the end-users of research and need research that address their individual healthcare needs. We aimed to understand the research priorities of end-users of asthma research. METHODS: A national cross-sectional mixed-methods study was conducted. The study included an online survey that engaged patients, carers, healthcare professionals and policymakers to provide statements to free-text questions about what they would like to see answered by research to improve living with asthma on a day-to-day basis. Responses where thematically analysed followed by three online priority setting consensus workshops. RESULTS: There were 593 respondents who provided 1446 text comments. Participants prioritized 10 asthma research themes which were: (1) asthma in children, (2) COVID 19 and asthma, (3) asthma care and self-management, (4) diagnosis and medication, (5) managing asthma attacks, (6) causes, prevention and features of asthma, (7) mental health, (8) asthma and ageing, (9) severe asthma, (10) asthma and other health conditions. Each theme comprises specific research questions. CONCLUSION: This project successfully established 10 priority research themes for asthma, reflecting the collective voice of the end-users of this research. These novel data can be used to address the documented mismatch in research prioritization between the research community and the end-users of research.


Subject(s)
Biomedical Research , COVID-19 , Child , Humans , Caregivers , Cross-Sectional Studies , COVID-19/epidemiology , Health Personnel , Surveys and Questionnaires
2.
Respirology ; 2022 Nov 30.
Article in English | MEDLINE | ID: covidwho-2230354
3.
JGH Open ; 6(6): 388-394, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1898848

ABSTRACT

Background and Aim: Nonspecific ileitis is inflammation of the ileum without specific diagnostic features. A minority may go on to develop Crohn's disease, but optimal pathways of further investigation have not been established. This study aimed to identify a cohort of patients with nonspecific ileitis and to determine the value of ileal histology and gastrointestinal ultrasound in identifying/excluding Crohn's disease. Patients and Methods: In a retrospective analysis, all patients having nonspecific ileitis at colonoscopy from January 2010 to August 2021 were identified. Clinical associations with those subsequently diagnosed with Crohn's disease were examined with specific reference to ileal histology and gastrointestinal ultrasound. Results: Of 29 638 procedures, 147 patients (0.5%) had nonspecific ileitis. Crohn's disease was subsequently diagnosed in 8 patients (5.4%) at a median of 148 (range 27-603) days after colonoscopy. The presence of chronic inflammation on ileal biopsies was more common in those subsequently diagnosed with Crohn's disease (63% vs 20%; P = 0.0145). On gastrointestinal ultrasound, none of the 26 patients with normal bowel wall thickness (<3 mm) were subsequently diagnosed with Crohn's disease, and repeat ultrasound in 15 patients 1 year later showed no change. Of the nine patients with abnormal sonographic findings, three were diagnostic for Crohn's disease. Repeat ultrasound revealed Crohn's disease in two, while four had resolution of the abnormal findings. Conclusion: Although ileal histology was of limited value in identifying patients with nonspecific ileitis who were subsequently diagnosed with Crohn's disease, gastrointestinal ultrasound was highly informative. Prospective studies are needed to confirm the value of gastrointestinal ultrasound as a diagnostic and monitoring tool in this setting.

4.
BMJ Open ; 12(6): e060272, 2022 06 10.
Article in English | MEDLINE | ID: covidwho-1891840

ABSTRACT

INTRODUCTION: Inflammatory bowel disease (IBD) involves an abnormal immune response to healthy gut bacteria. When a person develops IBD, their susceptibility to anxiety and/or depression increases. The ACTforIBD programme, specifically designed for people with IBD and comorbid psychological distress, draws on acceptance and commitment therapy (ACT), which promotes acceptance of situations that cannot be solved such as persistent physical symptoms. There are no ACT trials for IBD using an active control group or a telemedicine approach, which is important to improve accessibility, particularly in the context of the ongoing COVID-19 pandemic. The ACTforIBD programme is administered online with a 4-hour therapist involvement per participant only; if successful it can be widely implemented to improve the well-being of many individuals with IBD. METHODS AND ANALYSIS: Our team have codesigned with consumers the ACTforIBD programme, an 8-week intervention of 1-hour sessions, with the first three sessions and the last session delivered one-to-one by a psychologist, and the other sessions self-directed online. This study aims to evaluate the feasibility and preliminary efficacy of ACTforIBD to reduce psychological distress in patients with IBD. Using a randomised controlled trial, 25 participants will be randomised to ACTforIBD, and 25 patients to an active control condition. ETHICS AND DISSEMINATION: This protocol has been approved by Deakin University Research Ethics Committee in September 2021 (Ref. 2021-263) and the New Zealand Central Health and Disability Ethics Committee in December 2021 (Ref. 2021 EXP 11384). The results of this research will be published in peer-reviewed journals and shared with various stakeholders, including community members, policy-makers and researchers, through local and international conferences. TRIAL REGISTRATION NUMBER: ACTRN12621001316897.


Subject(s)
Acceptance and Commitment Therapy , Inflammatory Bowel Diseases , Psychological Distress , COVID-19 , Chronic Disease , Feasibility Studies , Humans , Inflammatory Bowel Diseases/psychology , Inflammatory Bowel Diseases/therapy , Pandemics , Quality of Life , Randomized Controlled Trials as Topic
5.
J Allergy Clin Immunol Pract ; 10(2): 609-611, 2022 02.
Article in English | MEDLINE | ID: covidwho-1683242
6.
Psychosociological Issues in Human Resource Management ; 9(2):77-90, 2021.
Article in English | ProQuest Central | ID: covidwho-1574393

ABSTRACT

. Empirical evidence on moral injury, psychological ill-health, and severe stress among COVID-19 frontline respiratory and intensive care physicians and nurses has been scarcely documented in the literature. Using and replicating data from BMA, CPHA, Gallup, NHS, NurseFly, Pew Research Center, Potloc, Prescott et al. (2020), Statista, TKW Research, and The University of Melbourne, we performed analyses and made estimates regarding how heightened levels of negative emotions are recurring among frontline medical workers possibly causing COVID-19 stress-related psychiatric disorders. Descriptive statistics of compiled data from the completed surveys were calculated when appropriate.

SELECTION OF CITATIONS
SEARCH DETAIL